Curanex Pharmaceuticals CURX Growth Metrics (2024-2025)

NASDAQ CURX
$5.27 +5.00 (+1,851.85%)
At close: Aug 20, 2026 · 4:00 PM EDT
Growth Metrics Dec2024 Sep2025 Dec2025
Growth Ratios
Assets Growth (1y) (Quarter) 2,135.83%
Assets (QoQ) (Quarter) 1,739.26%-20.02%
Cash & Equivalents Growth (1y) (Quarter) 2,286.46%3,240.12%
Cash & Equivalents (QoQ) (Quarter) -39.06%5,255.90%-14.71%
Cash from Operations Growth (1y) (Quarter) -6,970.04%-798.49%
Cash from Operations (QoQ) (Quarter) 26.56%90.67%
EBIT Growth (1y) (Quarter) -919.70%-1,998.61%
EBIT (QoQ) (Quarter) -57.96%-1,549.95%-225.09%
EBT Growth (1y) (Quarter) -1,179.00%-1,014.65%
EBT (QoQ) (Quarter) -197.39%-420.36%-159.18%
Enterprise Value Growth (1y) (Quarter) -2,286.46%-3,240.12%
Enterprise Value (QoQ) (Quarter) 39.06%-5,255.90%14.71%
EPS (Basic) Growth (1y) (Quarter) -19.91%-479.64%
EPS (Basic) (QoQ) (Quarter) 46.17%-387.85%-160.22%
EPS (Diluted) Growth (1y) (Quarter) -19.91%-479.64%
EPS (Diluted) (QoQ) (Quarter) 46.17%-387.85%-160.22%
Free Cash Flow Growth (1y) (Quarter) -6,970.04%-798.49%
Free Cash Flow (QoQ) (Quarter) 26.56%90.67%
Interest Coverage Ratio (QoQ) (Quarter) -1,070.71%
Net Cash Flow Growth (1y) (Quarter) 4,503.22%-798.49%
Net Cash Flow (QoQ) (Quarter) 26.56%-114.99%
Net Income Growth (1y) (Quarter) -1,179.00%-1,014.65%
Net Income (QoQ) (Quarter) -197.39%-420.36%-159.18%
Net Income towards Common Stockholders Growth (1y) (Quarter) -1,179.00%-1,014.65%
Net Income towards Common Stockholders (QoQ) (Quarter) -197.39%-420.36%-159.18%
Operating Income Growth (1y) (Quarter) -919.70%-1,998.61%
Operating Income (QoQ) (Quarter) -57.96%-1,549.95%-225.09%
Profit After Tax Growth (1y) (Quarter) -946.51%-2,005.76%
Profit After Tax (QoQ) (Quarter) -60.08%-1,480.98%-222.11%
Return on Assets (QoQ) (Quarter) 0.00
Return on Capital Employed (QoQ) (Quarter) -1618.00